Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • ascls.org
    • ascls.org

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society for Clinical Laboratory Science
  • ascls.org
    • ascls.org
  • My alerts
  • Log in
  • My Cart
American Society for Clinical Laboratory Science

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • Follow ASCLS on Twitter
  • Visit ASCLS on Facebook
  • Follow ASCLS on Instagram
  • RSS Feed
Research ArticleFocus: Hemorrhagic Abnormalities

Managing the Bleeding Patient

George A Fritsma
American Society for Clinical Laboratory Science April 2003, 16 (2) 107-110; DOI: https://doi.org/10.29074/ascls.16.2.107
George A Fritsma
is in the Department of Pathology, UAB Coagulation Service Coordinator at the University of Alabama at Birmingham, Birmingham AL
MS MT(ASCP)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gfritsma@path.uab.edu
  • Article
  • Info & Metrics
  • PDF
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

  1. George A Fritsma, MS MT(ASCP)⇑
    1. is in the Department of Pathology, UAB Coagulation Service Coordinator at the University of Alabama at Birmingham, Birmingham AL
  1. Address for correspondence: George A Fritsma MS MT (ASCP), Department of Pathology, 619 South 19th Street, West Pavilion, P230, University of Alabama at Birmingham, Birmingham AL 35249. gfritsma{at}path.uab.edu. Website: http://uabcoag.net

The reader will be able to:

  1. distinguish between anatomic and systemic hemorrhage.

  2. distinguish between acquired and congenital hemorrhage.

  3. select hemostatic laboratory tests that may be used to establish the presence of a hemostatic disorder.

  4. identify hemostatic laboratory tests for use in pinpointing the cause of hemorrhage.

  5. interpret the laboratory test profile results used to establish the presence of disseminated intravascular coagulation.

  6. interpret the laboratory test profile results used to establish the presence of von Willebrand disease.

  7. select single coagulation factor assays.

  8. describe how to perform and interpret mixing studies.

  9. determine the presence of a coagulation inhibitor.

  10. select the appropriate coagulation factor concentrate therapy to treat hemorrhagic disorders.

  11. calculate the correct dosage of coagulation factor concentrate to appropriately treat hemorrhagic disorders.

  12. assess the dosage adequacy of the coagulation factor concentrate used to treat hemorrhagic disorders.

  13. detail the selection and dosage of factor concentrates for von Willebrand disease, hemophilia, and hemophilia with the presence of an inhibitor.

Extract

The acute care hemostasis laboratory must be equipped to manage both acute and chronic hemorrhage. Hemorrhage is defined as bleeding that can be arrested only by special interventions such as pressure, elevation, ice, cauterization, ligation, or therapy.1 Therapy may include non-biologic drugs such as DDAVP and Amicar, and coagulation concentrates in various forms. Hemorrhage may be local or general, anatomic or systemic, acquired or congenital. To establish the cause for a hemorrhagic event, the clinician first completes a history and physical examination, and then follows up with diagnostic laboratory tests.2

LOCAL VERSUS GENERAL HEMORRHAGE Most bleeding is local. Hemorrhage from a single location signals a trauma, tissue necrosis, or a blood vessel defect. A surgical site may bleed because of an inadequately ligated or cauterized vessel. Local bleeding seldom implies a coagulopathy.

Bleeding is classified as general when it is excessive or when it originates from two or more sites (Table 1). Menorrhagia, hematemesis, epistaxis, bleeding from the gums, or bleeds into body cavities are signs of a hemostatic deficiency. Whenever such a coagulopathy is suspected, a careful workup involving hemostasis laboratory tests is essential.3,4

ACQUIRED VERSUS CONGENITAL HEMORRHAGIC DISORDERS Bleeding that first occurs in adulthood, is associated with a specific disorder (Table 2), and is not seen in kindred, implies an acquired hemorrhagic condition. When an adult patient presents with general hemorrhage, the physician first looks for an underlying disease, and then orders a hemostasis laboratory test profile.5

Congenital coagulopathies are uncommon, occurring in approximately one in 800 individuals,…

ABBREVIATIONS: PT = prothrombin time; PTT = partial thromboplastin time.

    INDEX TERMS
  • Anatomic hemorrhage
  • coagulopathy
  • systemic hemorrhage

The reader will be able to:

  1. distinguish between anatomic and systemic hemorrhage.

  2. distinguish between acquired and congenital hemorrhage.

  3. select hemostatic laboratory tests that may be used to establish the presence of a hemostatic disorder.

  4. identify hemostatic laboratory tests for use in pinpointing the cause of hemorrhage.

  5. interpret the laboratory test profile results used to establish the presence of disseminated intravascular coagulation.

  6. interpret the laboratory test profile results used to establish the presence of von Willebrand disease.

  7. select single coagulation factor assays.

  8. describe how to perform and interpret mixing studies.

  9. determine the presence of a coagulation inhibitor.

  10. select the appropriate coagulation factor concentrate therapy to treat hemorrhagic disorders.

  11. calculate the correct dosage of coagulation factor concentrate to appropriately treat hemorrhagic disorders.

  12. assess the dosage adequacy of the coagulation factor concentrate used to treat hemorrhagic disorders.

  13. detail the selection and dosage of factor concentrates for von Willebrand disease, hemophilia, and hemophilia with the presence of an inhibitor.

  • © Copyright 2003 American Society for Clinical Laboratory Science Inc. All rights reserved.
PreviousNext
Back to top

In this issue

American Society for Clinical Laboratory Science: 16 (2)
American Society for Clinical Laboratory Science
Vol. 16, Issue 2
Spring 2003
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Society for Clinical Laboratory Science.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Managing the Bleeding Patient
(Your Name) has sent you a message from American Society for Clinical Laboratory Science
(Your Name) thought you would like to see the American Society for Clinical Laboratory Science web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Managing the Bleeding Patient
George A Fritsma
American Society for Clinical Laboratory Science Apr 2003, 16 (2) 107-110; DOI: 10.29074/ascls.16.2.107

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Managing the Bleeding Patient
George A Fritsma
American Society for Clinical Laboratory Science Apr 2003, 16 (2) 107-110; DOI: 10.29074/ascls.16.2.107
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Laboratory Management of the Bleeding Patient
  • Use of Blood Products and Factor Concentrates for Coagulation Therapy
Show more Focus: Hemorrhagic Abnormalities

Similar Articles

Keywords

  • Anatomic hemorrhage
  • coagulopathy
  • systemic hemorrhage

© 2025 The American Society for Clinical Laboratory Science

Powered by HighWire